Sus Clinicals, Inc. is thrilled to announce a significant funding boost of $4,000,000, aimed at transforming the landscape of cancer treatment development. As a pioneering company resolving the critical challenges in qualifying new cancer drugs, devices, diagnostics, and therapies, Sus Clinicals employs a groundbreaking testing methodology using genetically-modified pigs, which was innovated at the University of Illinois. This unique approach allows the company to tap into the advantages of a patent-pending large animal testing framework, designed to minimize false positives while effectively simulating the complex interactions of various diseases. With this fresh capital, Sus Clinicals plans to accelerate its research initiatives, enhance its testing capabilities, and refine its proprietary models further. The funding will primarily support the advancement of the company's promising therapies toward human trials, ultimately making strides in the fight against cancer. This strategic investment not only underscores the confidence that investors have in Sus Clinicals' vision and technology but also highlights a collective commitment to improve patient outcomes in oncology. As we embark on this exciting journey, we are energized by the potential of our innovations to usher in a new era of accelerated drug development, offering hope for patients and their families affected by cancer. Stay tuned for more updates as we continue to pave the way for groundbreaking advancements in cancer therapeutics!
Revolutionizing Cancer Medicine: Sus Clinicals Secures $4 Million in Funding for Groundbreaking Research
Recently funded · $4.0MBiotechnology
Get the full Sus Clinicals, Inc. company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
